Search results
Results from the WOW.Com Content Network
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter ...
The Danish drugmaker Novo Nordisk said it has invested $6.5 billion this year in the United States to bolster drug production facilities that are operating 24/7, shipping Wegovy and Ozempic to ...
Some health care providers say they’re starting to feel more comfortable prescribing compounded versions of the blockbuster weight loss drugs Wegovy and Zepbound, even as others have lingering ...
A growing number of states are threatening to take legal action against pharmacies that make or dispense unauthorized versions of the weight-loss medications Ozempic and Wegovy.
The drugs have been in short supply since 2022, soon after the FDA approved Wegovy for weight loss purposes. Novo Nordisk said it made a $6.5 billion investment to increase production in the U.S.
Wegovy was launched in the U.S. in June 2021 but it took Novo until December 2022 to make all doses available there because of an initial production problem. ... a UK-based online pharmacy chain ...
(Reuters) -Novo Nordisk said on Thursday it had sued nine more medical spas, wellness clinics and pharmacies in the U.S. for selling products claiming to contain semaglutide, the key ingredient in ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce ...